Sunresin New Materials Co., Ltd., has signed a new agreement with Dutch biocatalysis specialist ChiralVision to provide end-to-end solutions in enzyme immobilization and biocatalytic process development.

The agreement strengthens an ongoing collaboration and combines Sunresin’s breadth of resin development and manufacturing capabilities with ChiralVision’s expertise in enzyme immobilization and enzymatic process engineering. Together, the two companies will develop and optimize novel applications using immobilized enzymes as well as offer enhanced support for existing processes.

A Partnership Built for Scale and Speed

By bringing together complementary strengths, Sunresin and ChiralVision are positioned to accelerate the development and commercialization of enzyme-based bioprocesses for their customers, from resin design, functionalization and production through to process development and optimization for specific applications.

Customers will benefit from:

• Access to a wide range of functionalized resins, including custom-designed supports optimized for specific enzymes and reactions

• In-house biocatalyst production, customized for end-user applications

• Expert development of robust immobilization processes with high efficiency and recovery

• Scalable production of immobilized biocatalysts aligned with end-user specifications

A Stronger Platform for Biocatalysis Innovation

“Working with Rob and the ChiralVision team over the past two decades, I’ve seen first-hand their invaluable knowledge and exceptional dedication to supporting customers,” said Dr. Alessandra Basso, Sales and Marketing Director at Sunresin. “Our expanded partnership reflects the success of numerous collaborative projects over the last two years—from early-stage testing to full-scale implementation. This partnership ensures our customers can access the best immobilized enzyme technologies, and implement them with greater speed, confidence and support.”

ChiralVision Managing Director, Rob Schoevaart added, “Our collaboration with Sunresin - one of the world’s leading and most innovative resin manufacturers - enables us to support larger and more complex development projects than ever before, and this partnership significantly strengthens our ability to scale up the commercial production of immobilized enzymes. Working with Alessandra and the Sunresin team brings a deep industry insight, dedication to innovation, and unwavering customer focus that makes them an ideal partner to bring new solutions to the industry."

The reinforced collaboration reflects a shared commitment to driving innovation in green chemistry, biotransformations, and industrial biocatalysis. With an expanding portfolio and proven ability to scale, Sunresin and ChiralVision are setting a new standard for customized, scalable enzyme immobilization solutions.

Alessandra Basso (Sunresin), Rob Schoevaart (ChiralVision) and Frank Galbrecht (Sunresin) celebrate their ongoing collaboration at Biotrans 2025

Sunresin operates 5 existing ISO-certified manufacturing facilities, and offices, logistics hubs and R&D centers across Asia, Europe, South America and North America. Pictured: Sunresin Headquarters, Xi'an, China